![N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacos an-16-yl)-2-hydroxy-2-[2-hydroxy-6-methyl-5-(2-methylbutyl)oxan-2-yl]propanamide](https://static.cymitquimica.com/products/3D/img/AFA22851.png "Clique para ampliar")
N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacos an-16-yl)-2-hydroxy-2-[2-hydroxy-6-methyl-5-(2-methylbutyl)oxan-2-yl]propanamide
CAS: 125228-51-5
Ref. 3D-AFA22851
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar |
Informação sobre produto
N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.0914]heptacos an-16yl)-2hydroxy 2-[2hydroxy 6methyl 5-(2methylbutyl)oxan 2yl]propanamide is a synthetic cyclic lipopeptide that inhibits the activity of leukocytes by binding to specific receptors on the cell surface and inhibiting their ion transport channels. It has been shown to decrease inflammatory response and immune system function in vitro and in vivo. In addition to its immunosuppressive properties it also has antiallergic effects by blocking the release of histamine from mast cells and inhibiting the production of pro
Propriedades químicas
Consulta técnica sobre: 3D-AFA22851 N-(7,21-Dihydroxy-6,20-dimethyl-2,5,8,15,19,22-hexaoxo-17-propan-2-yl-18-oxa-1,4,7,13,14,21,27-heptazatricyclo[21.4.0.09,14]heptacos an-16-yl)-2-hydroxy-2-[2-hydroxy-6-methyl-5-(2-methylbutyl)oxan-2-yl]propanamide
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
